Awards – November 2014

Federal Awards

Amatruda, James, Children’s Hospital of Philadelphia/NIH, COG Solid Malignancy Integrated Translational Science Center Grant, $13,177; Aquino, Victor, Natl Childhood Cancer Fdn/NIH, Primary Immune Deficiency Treatment Consortium - ARRA Stimulus Funding; #6901 and #6902, $500; Burgess, Shawn, NIH, Factors Controlling Metabolic Flux in Liver by NMR Isotopomer Analysis, $311,242; Chen, Chuo, NIH, Asymmetric Synthesis of Biologically Active Marine Natural Products, $269,838; Cleaver, Ondine, NIH, GTPases as Molecular Gatekeepers of Cytoskeletal and Cellular Polarization during Endothelial Tubulogenesis, $399,852; Crandall, Craig, NIH, Exercise in Burn Survivors - Diversity Supplement, $28,573; Desai, Dev, Stanford Univ/NIH, Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children, $37,659; Garg, Abhimanyu, NIH, Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients, $363,375;

Greenberg, Benjamin, University of California, San Fran/NIH, Environmental & Genetic Risk Factors for Peds MS, $17,490; Gumbo, Tawanda, Univ of Pennsylvania/NIH, Immune Activation and Isoniazid Metabolism in HIV/TB, $43,291; Hall, Christiana, Univ of Virginia/NIH, Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial, $181,929; Hsieh, Jer-Tsong, UT Dallas/NIH, Surface Chemistry for High-Contrast Fluorescent Kidney Imaging, $18,231; Johnson, Mark, Yale Univ/NIH, Insulin Resistance Intervention after Stroke (IRIS) Trial, $971; Kennard, Beth, NIH, 2/2 Brief Intervention for Suicide Risk Reduction in High Risk Adolescents, $178,875; Konopka, Genevieve (Fellow D. Araujo), Natl Science Fdn, Graduate Research Fellowship Program - Araujo, $44,000; Kramer, Helmut, NIH, Genetics of Endocytic Trafficking in the Drosophila Eye, $403,750; Levine, Benjamin, Natl Space Biomedical Research Inst, Developing a NASA/NSBRI Integrated Garment Solution to Mitigate Visual Impairment Intracranial Pressure Issues During Long Duration Space Flight, $10,000;

Luckett, Peter, Univ of California, San Fran/NIH, Coagulation and Fibrinolysis in a Pediatric Insulin Titration Trial Study Protocol Document; CAF-PINT, $10,000; Michaely, Peter, NIH, Characterization of Role of ARH on LDLR Function, $214,650; Nations, Sharon, Massachusetts General Hosp/NIH, A Phase II Trial of Rituximab In Myasthenia Gravis (NN103), $186,171; Nesbitt, Shawna, Minneapolis Medical Res Fdn/NIH, Aspirin in Reducing the Effects on the Elderly, $114,073; Nesbitt, Shawna, UTHSC Houston/NIH, Randomized Recruitment Intervention (RECRUIT), $1,000; Niederkorn, Jerry, NIH, Immunobiology of Corneal Allografts, $357,750; Niederkorn, Jerry, NIH, Immunological Modulation of Ocular Tumor Metastases, $253,953; Norgard, Michael, NIH, The RpoN-RpoS Regulatory Pathway in Borrelia Burgdorferi, $479,653; Paulk, Elizabeth, Dana-Farber Cancer Institute/NIH, Chemotherapy Near Death: Modifiable Factors and Outcomes in Ovarian Cancer, $5,563;

Perez-Fontan, Julio, NIH, Antecedents Sequelae of Childhood Onset Disease, $432,000; Raskin, Philip, Case Western Reserve Univ/NIH, Epidemiology of Diabetes Interventions and Complications (EDIC), $210,638; Raskin, Philip, George Washington Univ/NIH, Glycemia Reduction Approaches for Diabetes: Comparative Effectiveness (GRADE), $137,922; Schaffer, Joseph, RTI Internatl/NIH, NICHD Pelvic Floor Disorders Network - Capitation Funding, $13,417; Skapek, Stephen, Children’s Hosp of Philadelphia/NIH, COG Integrated Translational Science Center Grant, $33,826; Skapek, Stephen, Children’s Hosp of Philadelphia/NIH, NIH National Clinical Trials Network (NCTN) Scientific Leader, $14,048; Sperandio, Vanessa, NIH, Tryptophan Derivatives in EHEC Pathogenesis, $457,097; Starr, Adam, Johns Hopkins Univ/U.S. Dept of Defense, Major Extremity Trauma Research Consortium (METRC II), $19,927; Stull, James, UTHSC Houston/NIH, Mutations in Smooth Muscle Contractile Proteins: Pathway, $393,503;

Terman, Jonathan, NIH, Molecular Mechanisms of Axon Guidance and Neural Connectivity, $397,500; Toto, Robert, Univ of Pittsburgh/NIH, University of Pittsburgh Clinical and Translational Science Institute - ACTs, $400,203; Toto, Robert, Dartmouth College/NIH, SYNERGY: The Dartmouth Center for Clinical and Translational Science, $198,383; Wetzel, Dawn, NIH, Targeting Entry Pathways in Leishmaniasis, $131,795; Whitehurst, Angelique, NIH, Mechanistic Elaboration of Fragility in the Cancer Cell Mitotic Spindle, $289,480; Willson, James, Case Western Research Univ/NIH, Case Western GI SPORE, $98,622; Wu, Jiang, NIH, Role of autism-associated chromatin remodeler Brg1 in neuronal development, $178,875; Wu, Jiang (Fellow X. Shi), U.S. Dept of Defense, Function of Brg1 Chromatin Remodeling Factor in Sonic Hedgehog Dependent Medulloblastoma Initiation and Maintenance, $127,200; Wyckoff, Myra, RTI Internatl/NIH, NICHD Neonatal Research Network Capitation Funding, $5,595.

Nonfederal Awards

Abrams, John, Ellison Medical Fdn, Chromatin Interactions Assembled Through Long-Range p53 Enhancer Activity in Normal and Pathologic Aging, $238,500; Ahmad, Zahid, Duke Clin Res Inst/FH FDN, The Familial Hypercholesterolemia Foundation CASCADE-FH Registry, $500; Ariizumi, Kiyoshi, CPRIT, Targeting the DC-HIL Receptor for Anti-Cancer Immunotherapy, $392,724; Bowers, Daniel, St. Jude Children’s Research Hosp, Risk Adapted Therapy For Children Under 3 Yrs with Embryonal Brain Tumors, High-Grade Glioma, Choroid Plexus Carcinoma or Ependymoma, $6,250; Deberardinis, Ralph, V Fdn for Cancer Research, Translational Studies in Lung Cancer Metabolism: Creating new Paradigms in Diagnosis and Therapy, $200,000; Ding, Kan, Hosp for Sick Children/Epilepsy Fdn, Critical Care EEG Monitoring Research Consortium, $7,000; Greenberg, Benjamin, Patient-Centered Outcomes Research Inst, Collaborative Assessment of Pediatric Transverse Myelitis: Understand, Reveal, Educate (CAPTURE) Study, $460,187;

Hooper, Lora, Burroughs Wellcome Fund, Innate Immune Responses to Commensal Bacteria at Gut Epithelial Surfaces - Travel Award, $1,000; Husain, Mustafa, Univ of New South Wales, Controlled Trial of Transcranial Direct Current Stimulation as Treatment for Unipolar and Bipolar Depression, $15,000; Kapadia, Vishal, American Academy of Pediatrics, Novel Transitional Goal Saturations for Preterm Resuscitation in the Delivery Room, $50,000; Mahony, Lynn, Lurie Children’s Hosp of Chicago/Cincinnati Children’s Hosp, Testing the Pediatric Cardiac Quality of Life Inventory, $35,750; Mason, Ralph, Baylor Univ/CPRIT, Baylor: Targeting Hypoxia in Breast Cancer, $105,517; Olson, Daiwai, Duke Univ/U.S. Dept of Defense, PROSPER, $1,719; Rhee, Chanhaeng, UT System, Reducing Avoidable Harm from Device Related Healthcare Associated Infection (HAI), $165,000; Rosenbaum, Daniel, David and Lucille Packard Fdn, Structure Determination of Eukaryotic Membrane Proteins Using Thermophilic Variants, $175,000;

Shakil, Amer, Texas Academy of Family Physicians Fdn, Development and Validation of HITS Screening in Pediatric Populations, $4,584; Watt, Tanya, South Plains Oncology Consortium, SPOC 2014-001 Expanded Access Study of Fenretinide, $8,250; Zhang, Chengcheng, CPRIT, New Antibody Therapy for Treating Leukemia, $666,666; Zhang, Chengcheng, Leukemia & Lymphoma Society, Role of Angptl Receptor in Acute Myeloid Leukemia, $110,000; Zhu, Hao, CPRIT, Targeting the SWI/SNF Chromatin-Remodeling Complex in Liver Cirrhosis and Hepatocellular Carcinoma, $404,211.

Industry Sponsored Awards

(Dollar amounts not available)

Collins, Robert, Trial of Crenolanib and Chemotherapy in Pts with Newly Diagnosed Acute Myeloid Leukemia with FLT3 Activating Mutations, Arog Pharmaceuticals LLC; Collins, Robert, Phase 1 Study of Orally Admin AG-120 in Sbjs with Advanced Hematologic Malignancies with an IDH1 Mutation, INC Research; Falck, J Russell, Design and Synthesis of EET Mimetics; Servier Project, Medical College of Wisconsin; Gerber, David, Phase 3 Study of Alectinib vs. Crizotinib in Trtmt-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer, Genentech Inc; Huang, Chou-Long, Proposal to Characterize Bioactivity of Recombinant Klot, Boehringer Ingelheim Pharmaceuticals; Kaza, Vaidehi, Evaluation of DSA Post Lung Transplant, Washington University in St. Louis; Kumbhani, Dharam, Trial of Ticagrelor 90 mg Twice Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Pts with Type 2 Diabetes Mellitus, Clinical Financial Services;

Laetsch, Theodore, Phase 1/2 Study of PF-02341066, an Oral Small Molecule Inhibitor of Anaplastic Lymphoma Kinase (ALK) and C-Met, in Children with Relapsed/Refractory Solid Tumors and Anaplastic Large Cell Lymphoma, Children’s Hospital of Philadelphia; Laetsch, Theodore, Phase 2 Study of Oral Nilotinib in Pediatric Pts with Newly Diagnosed Ph+ Chronic Myelogenous Leukemia (MCL) in Chronic Phase (CP), Children’s Hospital of Philadelphia; Laetsch, Theodore, Phase 2 Trial of Pazopanib NSC#737754, IND#65747 in Children with Refractory Solid Tumors, Children’s Hospital of Philadelphia; Laetsch, Theodore, Phase 2 Preventative Trial of DFMO as Single Agent in Pts with High Risk Neuroblastoma in Remission, Spectrum Health Hospitals; Laetsch, Theodore, Phase 2 Trial of Nifurtimox for Refractory of Relapsed Neuroblastoma or Medulloblastoma, Spectrum Health Hospitals;

Lee, William, Phase 3 Study of Combination Regimen of MK-5172/MK-8742 in Treatment-Naive Sjbs with Chronic HCV GT1, GT4, GT5 and GT6 Infection on Opiate Substitution Therapy, Clinical Financial Services; Lotan, Yair, PRO-IMPACT-Study of Decipher Prostate Cancer Classifier on Treatment Consideration following Radical Prostatectomy, Genomedx Biosciences Inc; Nations, Sharon, Study of Eculizumab in Sbjs with Refractory Generalized Myasthenia Gravis (gMG), Quintiles Inc; Pan, Edward, Phase I/II Trial of Everolimus (RAD001) and Sorafenib in Pts with High-Grade Gliomas, UT MD Anderson Cancer; Schiller, Joan, Phase 3 Trial Comparing Veliparib Plus Carboplatin and Paclitaxel vs. Placebo Plus Carboplatin and Paclitaxel in Prev. Untreated Adv or Metastatic Squamous NSCLC, Abbvie Inc; Stuve, Olaf, AQP4 T-Cell Product Bioactivity Project, Opexa Therapeutics Inc;

Torrealba, Jose, Evaluation of Beta HE 600 Primary Staining Instrument, Ventana Medical Systems Inc; Van Buren, Peter, Phase 3 Study of Pyridorin in Sbjs with Nephropathy Due to Type 2 Diabetes, Medpace Inc; Wait, Michael, Study of Levosimendan In Pts with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass; LEVO-CTS, Duke Clinical Research Institute; Westover, Kenneth, Development of Covalent K-Ras Inhibitors, Dana-Farber Cancer Institute.